Johnson Pharmacare Ltd Stock Price Today (NSE: JOHNPHARMA)
Fundamental Score
Johnson Pharmacare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Johnson Pharmacare Ltd share price today is ₹0.55, up +0.00% on NSE/BSE as of 18 June 2026. Johnson Pharmacare Ltd (JOHNPHARMA) is a Small-cap company in the Diversified Commercial Services sector with a market capitalisation of ₹33.00 (Cr). The 52-week high for JOHNPHARMA share price is ₹0.93 and the 52-week low is ₹0.47. The company has a Return on Equity (ROE) of -0.44% and a debt-to-equity ratio of 0.02.
Johnson Pharmacare Ltd Share Price Chart — NSE/BSE Historical Performance
Johnson Pharmacare Ltd share price chart: -12.90% return over the past month. 52-week high ₹0.93, 52-week low ₹0.47.
Johnson Pharmacare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹0.55 | ₹0.55 | ₹0.54 | ₹0.55 | 4.68L (Cr) | |
| ₹0.54 | ₹0.55 | ₹0.53 | ₹0.55 | 5.60L (Cr) | |
| ₹0.55 | ₹0.55 | ₹0.53 | ₹0.54 | 10.23L (Cr) | |
| ₹0.55 | ₹0.55 | ₹0.54 | ₹0.54 | 4.11L (Cr) | |
| ₹0.55 | ₹0.55 | ₹0.54 | ₹0.55 | 3.40L (Cr) | |
| ₹0.54 | ₹0.56 | ₹0.54 | ₹0.54 | 6.63L (Cr) | |
| ₹0.56 | ₹0.56 | ₹0.54 | ₹0.55 | 6.19L (Cr) | |
| ₹0.54 | ₹0.58 | ₹0.53 | ₹0.56 | 9.55L (Cr) | |
| ₹0.53 | ₹0.54 | ₹0.53 | ₹0.54 | 5.69L (Cr) | |
| ₹0.53 | ₹0.56 | ₹0.53 | ₹0.54 | 9.33L (Cr) |
Johnson Pharmacare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹0.54 | ₹0.55 | ₹0.53 | ₹0.55 | +1.85% | |
| ₹0.59 | ₹0.60 | ₹0.51 | ₹0.54 | -8.47% | |
| ₹0.48 | ₹0.66 | ₹0.48 | ₹0.59 | +22.92% | |
| ₹0.51 | ₹0.57 | ₹0.47 | ₹0.48 | -5.88% | |
| ₹0.62 | ₹0.65 | ₹0.51 | ₹0.52 | -16.13% | |
| ₹0.58 | ₹0.60 | ₹0.50 | ₹0.51 | -12.07% | |
| ₹0.62 | ₹0.63 | ₹0.55 | ₹0.58 | -6.45% | |
| ₹0.63 | ₹0.70 | ₹0.59 | ₹0.61 | -3.17% | |
| ₹0.76 | ₹0.77 | ₹0.60 | ₹0.63 | -17.11% | |
| ₹0.77 | ₹0.85 | ₹0.75 | ₹0.76 | -1.30% | |
| ₹0.82 | ₹0.83 | ₹0.75 | ₹0.77 | -6.10% | |
| ₹0.89 | ₹0.93 | ₹0.82 | ₹0.82 | -7.87% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Zero revenue, zero promoter holding, zero reason to own this except pure gambling.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. The company announced the closure of its trading window for the quarter and year ended March 31, 2026. Board meetings were held in February 2026 to approve financial results and appoint an additional non-executive & independent director.
CORE STORY (THE REAL GAME)
A shell company trading shares, not a real business. Market likely ascribing optionality value to the listed entity, or pure speculation.
- Micro-cap stock, prone to manipulation
- Low debt, potential reverse merger target
- Recent board meetings, speculation of change
- Reverse merger announcement
- Significant order win (unlikely)
- Aggressive promoter buying (currently zero)
- Zero promoter holding
- No revenue or operations
- Negative ROE and ROCE
- Extremely illiquid micro-cap
- Dependence on speculation
No institutional interest. Promoter holding is zero.
India's diversified commercial services sector is seeing robust growth. However, Johnson Pharmacare is not participating in this growth.
Free cash flow is positive at ₹2.43 Cr over 5 years, but irrelevant given no operations.
Likely to remain a shell company unless a reverse merger occurs. Highly speculative.
Primary Thesis Risk
Complete collapse of value due to lack of business operations and zero promoter stake.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Johnson Pharmacare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Johnson Pharmacare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JOHNPHARMA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (-0.44%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.43%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Johnson Pharmacare Ltd vs Diversified Commercial Services Peers
Peer Comparison - Diversified Commercial Services
Compare Johnson Pharmacare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Johnson Pharmacare LtdJohnson Pharmac...Selected✓ JOHNPHARMA • 532154 | 0/100 | ₹0.55₹1 | ₹33.00₹33.00 | — — | -0.44%Poor -0.44% Poor | -0.43%Poor -0.43% Poor | 0.02Excellent 0.0 Excellent | — — | — — | 0.00% |
47/100 | ₹361.90₹362 | ₹14200.73₹14200.73 | 27.80Average 27.8 Average | 54.37%Excellent 54.37% Excellent | 68.01%Excellent 68.01% Excellent | 0.11Excellent 0.1 Excellent | — — | — — | 0.76% | |
Nesco LtdNesco Ltd... NESCO • 505355 | 62.7/100 | ₹1142.40₹1142 | ₹8886.83₹8886.83 | 21.49Average 21.5 Average | 15.82%Good 15.82% Good | 21.12%Excellent 21.12% Excellent | 0.04Excellent 0.0 Excellent | 10.75%Good 10.75% Good | 11.14%Good 11.14% Good | 0.52% |
CMS Info Systems LtdCMS Info System... CMSINFO • 543441 | 46.3/100 | ₹304.30₹304 | ₹5807.52₹5807.52 | 16.24Average 16.2 Average | 17.06%Good 17.06% Good | 23.67%Excellent 23.67% Excellent | 0.10Excellent 0.1 Excellent | 21.89%Excellent 21.89% Excellent | 11.88%Good 11.88% Good | 1.84% |
Smartworks Coworking Spaces LimitedSmartworks Cowo... SMARTWORKS • 544447 | 42.5/100 | ₹436.00₹436 | ₹5346.96₹5346.96 | — — | -81.99%Poor -81.99% Poor | 6.97%Poor 6.97% Poor | 8.60Poor 8.6 Poor | — — | 40.21%Excellent 40.21% Excellent | 0.00% |
NDR INVIT TrustNDR INVIT Trust... NDRINVIT • | 19.1/100 | ₹124.00₹124 | ₹4910.55₹4910.55 | 33.91Average 33.9 Average | 3.46%Poor 3.46% Poor | 4.74%Poor 4.74% Poor | 0.38Excellent 0.4 Excellent | — — | — — | 1.48% |
Indiqube Spaces LimitedIndiqube Spaces... INDIQUBE • 544454 | 43.4/100 | ₹158.27₹158 | ₹4541.16₹4541.16 | — — | -234.10%Poor -234.10% Poor | 4.76%Poor 4.76% Poor | 8.67Poor 8.7 Poor | — — | 34.61%Excellent 34.61% Excellent | 0.00% |
Nirlon LtdNirlon Ltd... NIRLON • 500307 | 59.1/100 | ₹599.25₹599 | ₹4469.06₹4469.06 | 14.06Average 14.1 Average | 59.88%Excellent 59.88% Excellent | 30.18%Excellent 30.18% Excellent | 2.47Poor 2.5 Poor | 14.71%Good 14.71% Good | 15.46%Excellent 15.46% Excellent | 5.24% |
Yaari Digital Integrated Services LtdYaari Digital I... YAARI • 533520 | 29.5/100 | ₹16.47₹16 | ₹4441.00₹4441.00 | 251.19Average 251.2 Average | — — | — — | 0.18Excellent 0.2 Excellent | 9.53%Good 9.53% Good | — — | 0.00% |
Hemisphere Properties India LtdHemisphere Prop... HEMIPROP • 543242 | 14.7/100 | ₹139.50₹140 | ₹3889.84₹3889.84 | — — | -1.99%Poor -1.99% Poor | -0.73%Poor -0.73% Poor | 0.20Excellent 0.2 Excellent | — — | — — | 0.00% |
Awfis Space Solutions LtdAwfis Space Sol... AWFIS • 544181 | 44/100 | ₹318.40₹318 | ₹3781.07₹3781.07 | 73.73Average 73.7 Average | 26.07%Excellent 26.07% Excellent | 12.90%Average 12.90% Average | 2.91Poor 2.9 Poor | 23.06%Excellent 23.06% Excellent | 39.77%Excellent 39.77% Excellent | 0.00% |
Top Diversified Commercial Services Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- International Gemmological Institute share price14200.73 Cr
- Nesco Ltd share price8886.83 Cr
- CMS Info Systems Ltd share price5807.52 Cr
- Smartworks Coworking Spaces Limited share price5346.96 Cr
- NDR INVIT Trust share price4910.55 Cr
Johnson Pharmacare Ltd Quarterly Performance
Latest quarterly metrics for JOHNPHARMA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Johnson Pharmacare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for JOHNPHARMA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Johnson Pharmacare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Johnson Pharmacare Ltd (JOHNPHARMA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Johnson Pharmacare Ltd
About JOHNPHARMA (Johnson Pharmacare Ltd)
Johnson Pharmacare Ltd is an emerging entity within the diversified commercial services sector, currently undergoing a transformative period. While its historical activities focuse...d primarily on trading shares and other investments, the company is strategically shifting its focus towards new avenues. This evolution marks a significant departure from its earlier operational model, suggesting a re-evaluation of its core competencies and market positioning. The transition involves a comprehensive assessment of potential growth areas and opportunities within the broader commercial services landscape. The company is actively exploring and evaluating various strategic options to revitalize its operations and establish a sustainable competitive advantage in a dynamic and evolving market environment. This strategic redirection signals a proactive approach to navigating the complexities of the modern business world. Johnson Pharmacare is diligently exploring new partnerships, technologies, and market segments to drive future growth. This may involve forging alliances with established players, investing in innovative technologies, or expanding into underserved geographic regions. These initiatives are aimed at developing a more robust and resilient business model that can withstand market fluctuations and capitalize on emerging trends. The company aims to leverage its existing resources and expertise to create value for stakeholders and establish itself as a reputable and reliable provider of commercial services. Originally incorporated in 1994 and based in Ahmedabad, India, Johnson Pharmacare Ltd, formerly known as Sun And Shine Worldwide Limited, adopted its current name in August 2021. This rebranding reflects the company's commitment to its new strategic direction and its aspiration to be a significant player in the healthcare-related services sector. The name change underscores the company's renewed focus and commitment to providing value-added services to its clients. Despite its modest beginnings, the company is determined to build a strong foundation for future growth and establish itself as a respected and trusted brand in the Indian commercial services market. The company is committed to ethical business practices, transparency, and delivering exceptional service to its stakeholders.
Company Details
Key Leadership
JOHNPHARMA Share Price: Frequently Asked Questions
What is the current share price of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd (JOHNPHARMA) trades at ₹0.55 on NSE and BSE. Market cap ₹33.00 (Cr). Educational data only.
What is the P/E ratio of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd has a P/E of N/Ax vs industry average 23.64x.
What is the Bull Run score for Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Johnson Pharmacare Ltd pay dividends?
Johnson Pharmacare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd has ROE of -0.44%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Johnson Pharmacare Ltd?
Johnson Pharmacare Ltd has debt-to-equity of 0.02.
Is Johnson Pharmacare Ltd a good investment?
Bull Run gives Johnson Pharmacare Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.